Vanguard Capital Management Establishes 5.09% Stake in Praxis Precision Medicines Inc (PRAX)

Vanguard Capital Management LLC has filed a Schedule 13G indicating a new substantial ownership position in Praxis Precision Medicines Inc (PRAX). As of the event date on March 31, 2026, the investment adviser reported beneficial ownership of 1,419,323 shares of common stock, representing 5.09% of the company. This filing marks an increase from a previous ownership level of 0.0%. The filing reveals that Vanguard exercises sole dispositive power over the entire 1,419,323 shares, while holding sole voting power over 197,379 shares. The securities were acquired in the ordinary course of business and are not held for the purpose of influencing or changing the control of the issuer. This aggregate ownership includes shares held by various Vanguard affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The filing was officially submitted on April 30, 2026, following the breach of the 5% ownership threshold.